Background: Mrityunjay Rasa is the one of the Kharaliya Kalpana explained in Yogaratnakara in Jwara chikitsa and indicated in all types of fever. Any pathology can leads to diseases which are easily seen by fever as a clinical symptom. Bacterial infections through the skin or by any system defiantly reflect through fever and as told in classics Mrityunjay Rasa is having the capacity to eradicate all types of Jwara. Aim & Objective: The study is planned to evaluate the antibacterial activity of Mrityunjay Rasa. Material and methods: Mrityunjay rasa was prepared according to Yogratnakar at the Department of Rasashastra & Bhaishajya Kalpana. The formulation was tested for organoleptic characters, physicochemical parameters and microbial specification tests. Observation and results: Standard Mrityunjay rasa can be prepared from three Bhawana of Ardraka swarasa each for an average of 11.55 hrs. Prepared Mrityunjay rasa was Reddish in color with a specific smell and 145.57% average yield. Analytical standards for Mrityunjay rasa such as loss on drying at 105oC, total ash, acid insoluble ash, alcohol soluble extractives, water-soluble extractive, pH, Hardness, Disintegration time and particle size were 2.10%, 15.87%, 2.43%, 2.29%, 20.43 %, 8.7 (10% aqueous solution), 3, 30 minutes 20 sec and 95.41 respectively. Mrityunjay Rasa has shown a better zone of inhibition against Staphylococcus aureus. Conclusion: Analytical parameters obtained through the present study can be considered as a reference standard for Mrityunjay rasa.
Introduction: Rasaushadhies (metal and mineral) preparations are unique preparations that include Bhasma, herbo-mineral preparations and Kupipakwa rasayana hold a significant place in Ayurvedic pharmaceutics. Nearly 70 % of formulations include a combination of one or more metallic/mineral with several herbs which have a supporting role in improving efficacy, relieving symptoms of the disease and to achieve long and healthy life. Shilasindur is a one of the Kupipakwa rasayana containing mercury, sulphur and arsenic disulphide and indicated in skin disorders, respiratory tract disorders and other infectious diseases. Aim and Objectives: Evaluation of repeated dose (Sub chronic) toxicity study of Shilasindur along with its characterization and antimicrobial activity. Materials & Methods: Shilasindur will be prepared in three batches as per classical reference and by using Electric Muffle furnace. The prepared formulation will be assessed with Organoleptic characters, physicochemical parameters and ICP – AES (Inductively coupled plasma atomic emission spectroscopy), FTIR (Fourier-transform infrared spectroscopy), XRD (X-Ray Diffraction). Sub chronic toxicity study will be carried out according to the OECD guidelines 408 and 452 as well as CCRAS guidelines of safety and toxicity. Epsilometer test (E-test) will be used to check antimicrobial activity of Shilasindur. Results: The analytical parameters will be assessed to establish the pharmaceutical standardization. Toxicity study will be done in three doses to ensure its safety. Statistical analysis will be done by applying unpaired t-test and ANOVA test. Conclusion: If significant positive results obtained in this work then it will be a valuable contribution and evidence that the drug Shilasindur is safe for consumption at treatment doses.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.